Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39


Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design.

MacPhail M, Schickli JH, Tang RS, Kaur J, Robinson C, Fouchier RA, Osterhaus AD, Spaete RR, Haller AA.

J Gen Virol. 2004 Jun;85(Pt 6):1655-63.


Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.

Durbin AP, Karron RA.

Clin Infect Dis. 2003 Dec 15;37(12):1668-77. Epub 2003 Nov 20.


Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine/human PIV-3 vaccine vector in rhesus monkeys.

Pennathur S, Haller AA, MacPhail M, Rizzi T, Kaderi S, Fernandes F, Bicha L, Schickli JH, Tang RS, Chen W, Nguyen N, Mathie S, Mehta H, Coelingh KL.

J Gen Virol. 2003 Dec;84(Pt 12):3253-61.


Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.

Tang RS, Schickli JH, MacPhail M, Fernandes F, Bicha L, Spaete J, Fouchier RA, Osterhaus AD, Spaete R, Haller AA.

J Virol. 2003 Oct;77(20):10819-28.


Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates.

Jin H, Cheng X, Traina-Dorge VL, Park HJ, Zhou H, Soike K, Kemble G.

Vaccine. 2003 Sep 8;21(25-26):3647-52.


A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.

Karron RA, Belshe RB, Wright PF, Thumar B, Burns B, Newman F, Cannon JC, Thompson J, Tsai T, Paschalis M, Wu SL, Mitcho Y, Hackell J, Murphy BR, Tatem JM.

Pediatr Infect Dis J. 2003 May;22(5):394-405.


Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.

Skiadopoulos MH, Schmidt AC, Riggs JM, Surman SR, Elkins WR, St Claire M, Collins PL, Murphy BR.

J Virol. 2003 Jan;77(2):1141-8.


Palivizumab in the prevention of respiratory syncytial virus disease.

Krilov LR.

Expert Opin Biol Ther. 2002 Oct;2(7):763-9. Review.


Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.

Murphy BR, Collins PL.

J Clin Invest. 2002 Jul;110(1):21-7. Review. No abstract available.


Respiratory syncytial virus: reverse genetics and vaccine strategies.

Collins PL, Murphy BR.

Virology. 2002 May 10;296(2):204-11. Review. No abstract available.


Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines.

Simoes EA, Tan DH, Ohlsson A, Sales V, Wang EE.

Vaccine. 2001 Dec 12;20(5-6):954-60.


Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults.

Power UF, Nguyen TN, Rietveld E, de Swart RL, Groen J, Osterhaus AD, de Groot R, Corvaia N, Beck A, Bouveret-Le-Cam N, Bonnefoy JY.

J Infect Dis. 2001 Dec 1;184(11):1456-60. Epub 2001 Nov 13.


Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.

Lee MS, Greenberg DP, Yeh SH, Yogev R, Reisinger KS, Ward JI, Blatter MM, Cho I, Holmes SJ, Cordova JM, August MJ, Chen W, Mehta HB, Coelingh KL, Mendelman PM.

J Infect Dis. 2001 Oct 1;184(7):909-13. Epub 2001 Aug 15.


Respiratory syncytial virus and parainfluenza virus.

Hall CB.

N Engl J Med. 2001 Jun 21;344(25):1917-28. Review. No abstract available.


Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR.

J Infect Dis. 2000 Nov;182(5):1331-42. Epub 2000 Sep 22.

Items per page

Supplemental Content

Write to the Help Desk